Welcome to eviQ
Select links to see the information eviQ has to support health professionals & patients and carers
eviQ Education is looking to develop a suite of resources to support an improvement in the education of patients being treated with oral antineoplastic agents and their carers. If you are an oncology health professional, we would greatly appreciate if you could complete this quick survey to assist us in gaining a clear idea of what education is currently being provided in Australian hospitals and clinics. It should take you no longer than 5 minutes to complete. Link to survey
If you have a particular interest in being further involved in the development of this project, please email us at firstname.lastname@example.org
Secondment opportunity to work with eviQ Education.
eviQ Education is offering 2 x 6 month 0.5 FTE secondments to 2 registered nurses to work as clinical content writers to review and update education materials developed by eviQ Education.
If you are interested in learning more please read the Expression of Interest flyer.
If you have any questions please email us on email@example.com.
Oral Antineoplastic Drugs: Education module for Community Pharmacists
This module will provide information on:
- General principles in cancer treatment
- Handling oral antineoplastic drugs and related wastes
- Oral antineoplastic prescriptions and protocols
- Adverse effects and supportive therapies
- Drug interactions
- Patient education
Click here to start the module.
Downloadable fact sheets for community pharmacists:
Translated Patient Information Sheets available!
eviQ has developed some new Patient Information Sheets about cancer treatments and their side effects. We hope that these will be useful for patients receiving cancer treatments, and their families.
The sheets have also been translated into 9 languages: Arabic, Chinese simplified, Chinese traditional, French, Greek, Italian, Korean, Spanish and Vietnamese.
Find out more here.
If you would like to subscribe to receive email notifications of new and updated protocols, please contact us.
Last updated 10th November 2015